{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:54:24Z","timestamp":1767135264202,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd011855","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,8,10]],"date-time":"2017-08-10T00:00:00Z","timestamp":1502323200000}}],"reference-count":54,"publisher":"Wiley","license":[{"start":{"date-parts":[[2017,8,10]],"date-time":"2017-08-10T00:00:00Z","timestamp":1502323200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,8,10]],"date-time":"2017-08-10T00:00:00Z","timestamp":1502323200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011855.pub2","type":"journal-article","created":{"date-parts":[[2017,8,10]],"date-time":"2017-08-10T01:24:50Z","timestamp":1502328290000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Palliative drug treatments for breathlessness in cystic fibrosis"],"prefix":"10.1002","author":[{"given":"Nishant","family":"Jaiswal","sequence":"first","affiliation":[{"name":"Advanced Pediatrics Centre, Post Graduate Institute of Medical Education and Research; ICMR Advanced Centre for Evidence-Based Child Health; Sector 12 Chandigarh India 160012"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meenu","family":"Singh","sequence":"additional","affiliation":[{"name":"Post Graduate Institute of Medical Education and Research; Department of Pediatrics; Sector 12 Chandigarh India 160012"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Advanced Pediatrics Centre, Post Graduate Institute of Medical Education and Research; ICMR Advanced Centre for Evidence-Based Child Health; Sector 12 Chandigarh India 160012"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiran K","family":"Thumburu","sequence":"additional","affiliation":[{"name":"Advanced Pediatrics Centre, Post Graduate Institute of Medical Education and Research; ICMR Advanced Centre for Evidence-Based Child Health; Sector 12 Chandigarh India 160012"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,8,10]]},"reference":[{"issue":"Suppl","key":"10.1002\/14651858.CD011855.pub2-BIB0001|cit1","first-page":"305","article-title":"Effect of hydrocodone on dyspnea, respiratory drive, and exercise performance in adult patients with cystic fibrosis","volume":"137","author":"Browning","year":"1988","journal-title":"American Review of Respiratory Disease"},{"issue":"1","key":"10.1002\/14651858.CD011855.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1164\/ajrccm.159.1.ats898","article-title":"Dyspnoea: mechanisms, assessment and management: a consensus statement","volume":"159","author":"American Thoracic Society","year":"1999","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"3","key":"10.1002\/14651858.CD011855.pub2-BIB0003|cit3","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011008.pub2","article-title":"Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness","author":"Barnes","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD011855.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/SPC.0b013e3282ffafe8","article-title":"Measurement of dyspnoea in the clinical rather than the research setting","volume":"2","author":"Bausewein","year":"2008","journal-title":"Current Opinion in Supportive and Palliative Care"},{"key":"10.1002\/14651858.CD011855.pub2-BIB0005|cit5","unstructured":"Bhatt J Smyth A Bertenshaw C Nottingham Children's Hospital. Guideline for the management of patients with cystic fibrosis www.nuh.nhs.uk\/handlers\/downloads.ashx?id=61166"},{"issue":"1","key":"10.1002\/14651858.CD011855.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1586\/17476348.3.1.21","article-title":"Pharmacological treatment of refractory breathlessness","volume":"3","author":"Booth","year":"2009","journal-title":"Expert Review of Respiratory Medicine"},{"key":"10.1002\/14651858.CD011855.pub2-BIB0007|cit7","unstructured":"Cystic Fibrosis Foundation Hope in our hands www.cff.org\/UploadedFiles\/aboutCFFoundation\/AnnualReport\/2010-Annual-Report.pdf"},{"key":"10.1002\/14651858.CD011855.pub2-BIB0008|cit8","unstructured":"Cystic Fibrosis Foundation About cystic fibrosis: what you need to know www.cff.org\/What-is-CF\/About-Cystic-Fibrosis\/"},{"key":"10.1002\/14651858.CD011855.pub2-BIB0009|cit9","unstructured":"Cystic Fibrosis Foundation 2012 Annual Report. More tomorrows today www.cff.org\/About-Us\/Assets\/2012-Annual-Report\/"},{"issue":"3","key":"10.1002\/14651858.CD011855.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1542\/peds.110.3.e38","article-title":"Nebulized morphine as a treatment for dyspnoea in a child with cystic fibrosis","volume":"110","author":"Cohen","year":"2002","journal-title":"Pediatrics"},{"issue":"21","key":"10.1002\/14651858.CD011855.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1001\/jama.2012.5853","article-title":"Inhaled hypertonic saline in infants and young children with cystic fibrosis","volume":"307","author":"Dasenbrook","year":"2012","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD011855.pub2-BIB0012|cit12","unstructured":"Deeks JJ Higgins JPT Altman DG editor(s) on behalf of the Cochrane Statistical Methods Group Chapter 9: Analysing data and undertaking meta-analysis. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"1","key":"10.1002\/14651858.CD011855.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jcf.2015.08.004","article-title":"Advance care planning in cystic fibrosis: current practices, challenges, and opportunities","volume":"15","author":"Dellon","year":"2016","journal-title":"Journal of Cystic Fibrosis"},{"issue":"3","key":"10.1002\/14651858.CD011855.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1183\/09031936.00099506","article-title":"Cystic fibrosis mortality and survival in the UK: 1947-2003","volume":"29","author":"Dodge","year":"2007","journal-title":"European Respiratory Journal"},{"issue":"3","key":"10.1002\/14651858.CD011855.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa043891","article-title":"Mucus clearance and lung function in cystic fibrosis with hypertonic saline","volume":"354","author":"Donaldson","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1002\/14651858.CD011855.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1513\/AnnalsATS.201501-034OC","article-title":"Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease. A systematic review.","volume":"12","author":"Ekstr\u00f6m","year":"2015 July","journal-title":"Ann Am Thorac Soc"},{"key":"10.1002\/14651858.CD011855.pub2-BIB0017|cit17","doi-asserted-by":"crossref","unstructured":"Ekstr\u00f6m M, Bajwah S, Bland JM, Currow DC, Hussain J, Johnson MJ. One evidence base; three stories: do opioids relieve chronic breathlessness? Thorax Published Online First: 04 April 2017","DOI":"10.1136\/thoraxjnl-2016-209868"},{"issue":"1","key":"10.1002\/14651858.CD011855.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD011855.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1586\/14787210.2015.1025056","article-title":"Clinical and in vitro evidence for the antimicrobial therapy in Burkholderia cepacia complex infections","volume":"13","author":"Gautam","year":"2015","journal-title":"Expert Review of Anti-infective therapy"},{"issue":"6","key":"10.1002\/14651858.CD011855.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/j.2048-7940.1989.tb01129.x","article-title":"Validation of a vertical visual analogue scale as a measure of clinical dyspnea","volume":"14","author":"Gift","year":"1989","journal-title":"Rehabilitation Nursing"},{"issue":"1","key":"10.1002\/14651858.CD011855.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jcf.2015.08.005","article-title":"CF healthcare workers feel unprepared in providing suitable end of life care and desire more education: results of a nationwide survey","volume":"15","author":"Goggin","year":"2016","journal-title":"Journal of Cystic Fibrosis"},{"issue":"6","key":"10.1002\/14651858.CD011855.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1159\/000081769","article-title":"Nebulized fentanyl for palliation of dyspnoea in a cystic fibrosis patient","volume":"71","author":"Graff","year":"2004","journal-title":"Respiration"},{"issue":"9","key":"10.1002\/14651858.CD011855.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2146\/ajhp080188","article-title":"Inhaled morphine for palliation of dyspnea in end-stage cystic fibrosis","volume":"67","author":"Hayes","year":"2010","journal-title":"American Journal of Health-system Pharmacy"},{"key":"10.1002\/14651858.CD011855.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.prrv.2007.02.009","article-title":"Mucolytics in cystic fibrosis","volume":"8","author":"Henke","year":"2007","journal-title":"Paediatric Respiratory Reviews"},{"issue":"7414","key":"10.1002\/14651858.CD011855.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011855.pub2-BIB0026|cit26","unstructured":"Higgins JPT Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD011855.pub2-BIB0027|cit27","unstructured":"Higgins JPT Deeks JJ editor(s) Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD011855.pub2-BIB0028|cit28","unstructured":"Higgins JPT Altman DG Sterne JAC editors(s) on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD011855.pub2-BIB0029|cit29","unstructured":"Higgins JPT Deeks JJ Altman DG editor(s) on behalf of the Cochrane Statistical Methods Group Chapter 16: Special topics in statistics. In: Higgins JPT, Green S, editor(s). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"6","key":"10.1002\/14651858.CD011855.pub2-BIB0030|cit30","first-page":"729","article-title":"The Borg scale is accurate in children and adolescents older than 9 years with cystic fibrosis","volume":"55","author":"Hommerding","year":"2010","journal-title":"Respiratory Care"},{"issue":"3","key":"10.1002\/14651858.CD011855.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/1099-0496(200009)30:3<257::AID-PPUL10>3.0.CO;2-R","article-title":"Inhaled morphine to relieve dyspnea in advanced cystic fibrosis lung disease","volume":"30","author":"Janahi","year":"2000","journal-title":"Pediatric Pulmonology"},{"issue":"11","key":"10.1002\/14651858.CD011855.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1136\/thorax.57.11.939","article-title":"A systematic review of the use of opioids in the management of dyspnoea","volume":"57","author":"Jennings","year":"2002","journal-title":"Thorax"},{"issue":"7","key":"10.1002\/14651858.CD011855.pub2-BIB0033|cit33","first-page":"900","article-title":"The role of inhaled opioids and furosemide for the treatment of dyspnea","volume":"52","author":"Kallet","year":"2007","journal-title":"Respiratory Care"},{"key":"10.1002\/14651858.CD011855.pub2-BIB0034|cit34","first-page":"1-18.10","article-title":"Dyspnea: mechanisms, measurement and management","volume-title":"History of dyspnoea","author":"Killian","year":"2005"},{"issue":"7","key":"10.1002\/14651858.CD011855.pub2-BIB0035|cit35","first-page":"16","article-title":"Cystic fibrosis: newborn screening in America","volume":"40","author":"Kleven","year":"2008","journal-title":"Medical Laboratory Observer"},{"issue":"1","key":"10.1002\/14651858.CD011855.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jcf.2015.03.005","article-title":"Development and evaluation of a palliative care curriculum for cystic fibrosis healthcare providers","volume":"15","author":"Linnemann","year":"2015","journal-title":"Journal of Cystic Fibrosis"},{"issue":"1","key":"10.1002\/14651858.CD011855.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jcf.2015.11.007","article-title":"End of Life: Have we got it right?","volume":"15","author":"Madge","year":"2016","journal-title":"Journal of Cystic Fibrosis"},{"issue":"9678","key":"10.1002\/14651858.CD011855.pub2-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1016\/S0140-6736(09)60327-5","article-title":"Cystic fibrosis","volume":"373","author":"O'Sullivan","year":"2009","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD011855.pub2-BIB0039|cit39","unstructured":"Hospice Palliative Care Federation of Massachusetts Palliative sedation protocol: A report of the Standards and Best Practices Committee Hospice & Palliative Care Federation of Massachusetts April 2004 c.ymcdn.com\/sites\/www.hospicefed.org\/resource\/resmgr\/hpcfm_pdf_doc\/pal_sed_protocol_2004.pdf"},{"issue":"4","key":"10.1002\/14651858.CD011855.pub2-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1164\/rccm.201111-2042ST","article-title":"An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnoea","volume":"185","author":"Parshall","year":"2012","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"25","key":"10.1002\/14651858.CD011855.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"8177","DOI":"10.1523\/JNEUROSCI.1375-09.2009","article-title":"Opioids depress cortical centers responsible for the volitional control of respiration","volume":"29","author":"Pattinson","year":"2009","journal-title":"Journal of Neuroscience"},{"key":"10.1002\/14651858.CD011855.pub2-BIB0042|cit42","article-title":"Dyspnoea in chronic obstructive pulmonary disorder","volume-title":"Dyspnoea in advanced disease:a guide to clinical management","volume":"74","author":"Peters","year":"2006"},{"issue":"6","key":"10.1002\/14651858.CD011855.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1378\/chest.08-1190","article-title":"Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-Revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection","volume":"135","author":"Quittner","year":"2009","journal-title":"Chest"},{"key":"10.1002\/14651858.CD011855.pub2-BIB0044|cit44","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"2","key":"10.1002\/14651858.CD011855.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/10966210050085250","article-title":"Palliative care in cystic fibrosis","volume":"3","author":"Robinson","year":"2000","journal-title":"Journal of Palliative Medicine"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD011855.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/S1569-1993(11)60007-6","article-title":"End of life care for patients with cystic fibrosis","volume":"10","author":"Sands","year":"2011","journal-title":"Journal of Cystic Fibrosis"},{"issue":"12","key":"10.1002\/14651858.CD011855.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1089\/jpm.2012.0249","article-title":"Acceptability and preferences of six different routes of drug application for acute breathlessness: a comparison study between the United Kingdom and Germany","volume":"15","author":"Simon","year":"2012","journal-title":"Journal of Palliative Medicine"},{"key":"10.1002\/14651858.CD011855.pub2-BIB0048|cit48","unstructured":"Sterne JAC Egger M Moher D editor(s) on behalf of the Cochrane Bias Methods Group Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S, editor(s). Cochrane Handbook forSystematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.handbook.cochrane.org"},{"issue":"1","key":"10.1002\/14651858.CD011855.pub2-BIB0049|cit49","first-page":"29","article-title":"Core palliative medicines: meeting the needs of non-complex community patients","volume":"43","author":"Tait","year":"2014","journal-title":"Australian Family Physician"},{"issue":"10","key":"10.1002\/14651858.CD011855.pub2-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1001\/jama.302.10.1130.","article-title":"Cystic fibrosis","volume":"302","author":"Torpy","year":"2009","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD011855.pub2-BIB0051|cit51","unstructured":"UK Cystic Fibrosis Registry Annual data report 2013 www.cysticfibrosis.org.uk\/media\/598466\/annual-data-report-2013-jul14.pdf"},{"issue":"1","key":"10.1002\/14651858.CD011855.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1385\/CRIAI:23:1:077","article-title":"Airways reactivity in patients with CF","volume":"23","author":"Weinberger","year":"2002","journal-title":"Clinical Reviews in Allergy and Immunology"},{"key":"10.1002\/14651858.CD011855.pub2-BIB0053|cit53","unstructured":"WHO Genomic Resource Centre Genes and human diseases: cystic fibrosis www.who.int\/genomics\/public\/geneticdiseases\/en\/index2.html"},{"issue":"9","key":"10.1002\/14651858.CD011855.pub2-BIB0054|cit54","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011855","article-title":"Drug treatments for breathlessness in end-stage cystic fibrosis","author":"Jaiswal","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd011855.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD011855.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T19:00:26Z","timestamp":1628535626000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD011855.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Cystic Fibrosis and Genetic Disorders Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,8,10]]},"references-count":54,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011855.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,10]]}}}